Ozempic/Wegovy success triggers patent 'gold rush' for weight loss drugs
Huge numbers of applications have been made over the past five years with Chinese innovators now challenging Novo Nordisk for pole position Register for limited access Register to receive our newsletter and gain limited access to subscriber content. …